Angel Rivero
Badalona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Evaluation of Dual Path Platform optical density in relation to RPR titers and serological response in syphilis: a cross-sectional and longitudinal study.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: June 25, 2026
Closing the PrEP access gap in Europe: a strategic framework for equity and innovation among difficult-to-reach populations.
Journal: The Journal of antimicrobial chemotherapy
Published: February 13, 2026
Implementing Semi-Automated Medication Dispensing for People with HIV: A Community-Based Alternative to Traditional Pharmacy Pickups.
Journal: Healthcare (Basel, Switzerland)
Published: January 05, 2026
Incidence and Clinical, Virological, and Resistance Characteristics of HIV Infections Among pre-Exposure Prophylaxis Users in Spain (SCOPE Study): A Multicentre Prospective and Retrospective Cohort Study.
Journal: The Lancet regional health. Europe
Published: December 10, 2025
Strategies to Minimize Time From HIV Acquisition to ART Initiation: The Barcelona Early-cART Program.
Journal: Open forum infectious diseases
Published: July 03, 2025
HCV infection, risk factors and PrEP use among HIV-negative MSM and TW at a community health centre.
HCV infection, risk factors and PrEP use among HIV-negative MSM and TW at a community health centre.
Journal: Journal of infection and public health
Published: June 16, 2025
Bictegravir/emtricitabine/tenofovir alafenamide for primary HIV infection: Efficacy, safety and impact on viral reservoir (the BIC-PHI clinical trial).
Journal: The Journal of infection
Published: May 19, 2025
Target Trial Emulation of the Modified Vaccinia Ankara-Bavarian Nordic Vaccine for Pre-Exposure Mpox Prevention in At-Risk Populations.
Journal: Vaccines
Published: April 23, 2025
Exploring the acceptability, appropriateness, feasibility and satisfaction of an implementation strategy for out-of-HOspital administration of the Long-Acting combination of cabotegravir and rilpivirine as an optional therapy for HIV in Spain (the HOLA study)-a hybrid implementation-effectiveness, phase IV, double-arm, open-label, multicentric study: study protocol.
Journal: BMJ open
Published: April 11, 2025
Rapid clearance of inducible HIV-1 proviruses after initiation of antiretroviral therapy.
Journal: PLoS pathogens
Published: March 03, 2025
Impact of Dolutegravir Plus Lamivudine as First-line Antiretroviral Treatment on the Human Immunodeficiency Virus Type 1 Reservoir and Inflammatory Markers in Peripheral Blood.
Journal: The Journal of infectious diseases
Published: May 23, 2024
Immune responses associated with mpox viral clearance in men with and without HIV in Spain: a multisite, observational, prospective cohort study.
Journal: The Lancet. Microbe
Published: September 20, 2023
Last Updated: 09/26/2026